BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25714282)

  • 1. Characterization of adrenal lesions at chemical-shift MRI: a direct intraindividual comparison of in- and opposed-phase imaging at 1.5 T and 3 T.
    Ream JM; Gaing B; Mussi TC; Rosenkrantz AB
    AJR Am J Roentgenol; 2015 Mar; 204(3):536-41. PubMed ID: 25714282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.
    Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J
    AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures.
    Mayo-Smith WW; Lee MJ; McNicholas MM; Hahn PF; Boland GW; Saini S
    AJR Am J Roentgenol; 1995 Jul; 165(1):91-5. PubMed ID: 7785642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of adrenal lesions with 1.5-T MRI: preliminary observations on comparison of three in-phase and out-of-phase gradient-echo techniques.
    Ramalho M; de Campos RO; Heredia V; Dale BM; Tannaphai P; Azevedo RM; Semelka RC
    AJR Am J Roentgenol; 2011 Aug; 197(2):415-23. PubMed ID: 21785088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience.
    Schindera ST; Soher BJ; Delong DM; Dale BM; Merkle EM
    Radiology; 2008 Jul; 248(1):140-7. PubMed ID: 18566172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of chemical shift subtraction MRI in characterization of adrenal masses.
    Savci G; Yazici Z; Sahin N; Akgöz S; Tuncel E
    AJR Am J Roentgenol; 2006 Jan; 186(1):130-5. PubMed ID: 16357391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of adrenal lesions: comparison of 2D and 3D dual gradient-echo MR imaging at 3 T--preliminary results.
    Marin D; Soher BJ; Dale BM; Boll DT; Youngblood RS; Merkle EM
    Radiology; 2010 Jan; 254(1):179-87. PubMed ID: 20032151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of adrenal lesions using chemical shift MRI: comparison between 1.5 Tesla and two echo time pair selection at 3.0 Tesla MRI.
    Nakamura S; Namimoto T; Morita K; Utsunomiya D; Oda S; Nakaura T; Hirai T; Yamashita Y
    J Magn Reson Imaging; 2012 Jan; 35(1):95-102. PubMed ID: 22002867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging.
    Korobkin M; Lombardi TJ; Aisen AM; Francis IR; Quint LE; Dunnick NR; Londy F; Shapiro B; Gross MD; Thompson NW
    Radiology; 1995 Nov; 197(2):411-8. PubMed ID: 7480685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas.
    Israel GM; Korobkin M; Wang C; Hecht EN; Krinsky GA
    AJR Am J Roentgenol; 2004 Jul; 183(1):215-9. PubMed ID: 15208141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
    Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
    Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined chemical shift imaging with early dynamic serial gadolinium-enhanced MRI in the characterization of adrenal lesions.
    Rodacki K; Ramalho M; Dale BM; Battisti S; de Campos RO; Giardino A; Semelka RC
    AJR Am J Roentgenol; 2014 Jul; 203(1):99-106. PubMed ID: 24951201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas.
    Namimoto T; Yamashita Y; Mitsuzaki K; Nakayama Y; Makita O; Kadota M; Takahashi M
    Radiology; 2001 Mar; 218(3):642-6. PubMed ID: 11230633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Versus Qualitative Methods in Evaluation of T2 Signal Intensity to Improve Accuracy in Diagnosis of Pheochromocytoma.
    Borhani AA; Hosseinzadeh K
    AJR Am J Roentgenol; 2015 Aug; 205(2):302-10. PubMed ID: 26204279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases.
    Halefoglu AM; Altun I; Disli C; Ulusay SM; Ozel BD; Basak M
    J Comput Assist Tomogr; 2012; 36(4):367-74. PubMed ID: 22805662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation.
    Fujiyoshi F; Nakajo M; Fukukura Y; Tsuchimochi S
    AJR Am J Roentgenol; 2003 Jun; 180(6):1649-57. PubMed ID: 12760936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses.
    Park BK; Kim CK; Kim B; Lee JH
    Radiology; 2007 Jun; 243(3):760-5. PubMed ID: 17517932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of MRI to Differentiate Clear Cell Renal Cell Carcinoma Adrenal Metastases From Adrenal Adenomas.
    Schieda N; Krishna S; McInnes MDF; Moosavi B; Alrashed A; Moreland R; Siegelman ES
    AJR Am J Roentgenol; 2017 Sep; 209(3):W152-W159. PubMed ID: 28742373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
    Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
    Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of adrenal masses using MR imaging with histopathologic correlation.
    Heinz-Peer G; Hönigschnabl S; Schneider B; Niederle B; Kaserer K; Lechner G
    AJR Am J Roentgenol; 1999 Jul; 173(1):15-22. PubMed ID: 10397092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.